Home
/
LifeStance Health Group, Inc.
/
Financials
/
Quarterly
LifeStance Health Group, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LifeStance Health Group, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$363.81M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$345.31M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$332.97M
May 7, 2025
Q3
2025
Sep 30, 2024
$312.72M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$312.33M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$300.44M
May 7, 2025
Q3
2024
Sep 30, 2023
$262.90M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$259.58M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$252.59M
May 9, 2024
Q3
2023
Sep 30, 2022
$217.56M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$209.53M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$203.10M
May 10, 2023
Q3
2022
Sep 30, 2021
$173.84M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$160.55M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$143.13M
May 11, 2022
Q3
2021
Sep 30, 2020
$101.98M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$45.45M
Aug 12, 2021
Q3
2021
May 14, 2020
$111.66M
Nov 10, 2021
Q2
2021
May 14, 2020
$38.56M
Aug 12, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$1.45M
Nov 10, 2021
Q2
2021
Jun 30, 2021
$1.36M
Aug 12, 2021
Q3
2021
Sep 30, 2020
$44.0K
Nov 10, 2021
Q2
2021
Jun 30, 2020
$16.0K
Aug 12, 2021
Q3
2021
May 14, 2020
$14.0K
Nov 10, 2021
Q2
2021
May 14, 2020
$14.0K
Aug 12, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.08M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($3.79M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$709.0K
May 7, 2025
Q3
2025
Sep 30, 2024
($5.96M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($23.28M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($21.10M)
May 7, 2025
Q3
2024
Sep 30, 2023
($61.58M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($45.48M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($34.24M)
May 9, 2024
Q3
2023
Sep 30, 2022
($37.85M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($68.73M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($62.33M)
May 10, 2023
Q3
2022
Sep 30, 2021
($120.45M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($70.03M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($8.68M)
May 11, 2022
Q3
2021
Sep 30, 2020
($3.29M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($4.34M)
Aug 12, 2021
Q2
2021
May 14, 2020
($27.60M)
Aug 12, 2021
Q3
2021
May 14, 2020
($24.95M)
Nov 10, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$7.41M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($2.95M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.60M
May 7, 2025
Q3
2025
Sep 30, 2024
$47.0K
Nov 6, 2025
Q2
2025
Jun 30, 2024
($15.95M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($16.77M)
May 7, 2025
Q3
2024
Sep 30, 2023
($74.36M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($48.41M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($34.09M)
May 9, 2024
Q3
2023
Sep 30, 2022
($38.84M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($60.47M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($64.85M)
May 10, 2023
Q3
2022
Sep 30, 2021
($124.67M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($47.05M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($881.0K)
May 11, 2022
Q3
2021
Sep 30, 2020
$2.69M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$104.0K
Aug 12, 2021
Q3
2021
May 14, 2020
$8.70M
Nov 10, 2021
Q2
2021
May 14, 2020
$3.06M
Aug 12, 2021